Clinical Trial Update: Memantine and Changes of Biological Markers and Brain PET Imaging in Alzheimer's Disease [Phase 4]

View source ↗

Summary

A Phase 4 trial assessing memantine's effects on biological markers and brain PET imaging in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Memantine (memantine)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Alzheimer's Disease | Phase 4 | Status: COMPLETED